Rite Aid Corporation

Drug store chain

Based in PA

🤖

AI Overview

With $1.4M in lobbying spend across 27 quarterly filings, Rite Aid Corporation is a significant lobbying presence. They deploy 15 individual lobbyists

$1.4M
Total Lobbying Spend
27
Quarterly Filings
1
Lobbying Firms Used
15
Individual Lobbyists

Spending by Year

YearLobbying Spend
2018$220K
2019$200K
2020$150K
2021$150K
2022$200K
2023$200K
2024$200K
2025$30K

Lobbying Firms

CAPITOL COUNSEL LLC

What They Lobby For

  • Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54); and Issues related to TRICARE in HR 1735, the National Defense authorization Act of FY 2017.
  • Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act.
  • Legislative issues relating to the Supplemental Nutrition Assistance Program (SNAP) Retailer Eligibility Standards proposed rule.
  • Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54).
  • Legislative and regulatory issues related to pharmacies. Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54). Coronavirus response efforts.
  • Legislative and regulatory issues related to pharmacies. Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act. Coronavirus response efforts.
  • Legislative and regulatory issues related to pharmacies. Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act. Coronavirus response efforts.
  • Monitoring legislative and regulatory issues related to pharmacies. Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54) and PBM reform including S.2973 - Modernizing and Ensuring PBM Accountability Act and H.R.5378 - Lower Costs, More Transparency Act.
  • Monitoring legislative and regulatory issues related to pharmacies. Medication therapy management. Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act.
  • Monitoring legislative and regulatory issues related to pharmacies. Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act.

Related Investigations

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.